Informa

27^th - 29^th May, 2020
Mumbai, India

Refer your pharma colleague

from

Regulatory Affairs | R&D | Compliance
Policy Makers and Strategists |Quality Assurance and Control

Refer Now

Industry Landscape

Globally, Indian pharma has contributed to improve public health outcomes. India accounts for 60% of global vaccine production, contributing 40 to 70% of the WHO demand for Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90% of the WHO demand for the measles vaccine. Estimates suggest that one in every three pills consumed in the United States is produced by an Indian generics manufacturer. In the UK, approximately 25% of the medicines used are made in India.

Why this Forum

The 9th Edition Global Pharma Regulatory Summit organized by CPhI Conferences will witness a gathering of senior leaders and experts of regulatory affairs, compliances, quality assurance and policy makers to discuss and share their perspectives on current trends and challenges in global regulatory landscape. The themes are designed to inspire and enable the brilliant minds from across the pharma ecosystem to come together to examine, discuss and debate how to improve regulatory system and lower the challenges associated

Who Should Attend?

The 9^th Global Pharma Regulatory Summit will bring together leading Regulatory experts and decision makers from across the pharma industry. These delegates will be attending this summit to learn about the latest updates on regulations, best practice and compliance advances in the sector and much more.

The Global Pharma Regulatory Summit is designed for

Designation

VP’s; Directors; HODs

Sr. Managers / General Managers

Managers/ Deputy Managers

Executives

Programme Focus

World renowned speaker sharing their thoughts on current amendments
by USFDA, MHRA, ANVISA and Medicines for Europe

Presentations by industry experts on Price
Regulations, Clinical Trial, etc

In-depth panel discussions on global regulatory updates, Biopharma
growth and regulatory perspectives in India

Overview of Nitrosamines Impurities and current
regulations on Impurity Profiling

Why Attend

Access the latest information and insights on global regulatory affairs program

Analyze how stakeholders around the world are supporting regulatory system optimization

Examine the
impact of new initiatives for emerging markets

Network with innovators and opinion leaders in the pharma regulatory affairs arena

Glimpses & Testimonials

The conference helped us in gaining experience from Industry experts on the practical examples shared by the speakers on how these guidelines work actually in the regulatory framework

Vinaya Shenoy
GSK Asia Pvt. Ltd.

Selection of topics & presentations from the industry experts is the key factor which differentiates this conference from others. This is a very professional & well planned event

Mr. Rakesh Jarwekar
Cipla Ltd

GPRS is one of the most important summit for spreading knowledge of regulatory professional. Nice arrangement and more important topics has been discussed by experts

Mr. Md. Aby Kawsar
Eskayef Pharmaceuticals Ltd.

GET YOUR SALES BROCHURE

Full speaker list

Download Brochure

GET YOUR DELEGATE BROCHURE

Full speaker list • Full conference agenda